| Sep 22 |
Takeda Pharmaceutical Company Limited (TAK): Hedge Funds Are Bullish On This Japanese Stock Now
|
| Sep 19 |
Takeda to Present Additional Clinical Trial Study Data Highlighting the Impact of Orexin Agonist TAK-861 on the Burden of Narcolepsy at Sleep Europe 2024
|
| Sep 19 |
Lupin and Takeda to commercialise Vonoprazan in India
|
| Sep 18 |
Takeda commits over $32M in five new CSR partnerships
|
| Sep 18 |
Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships to Further Drive Health Impact in 93 Countries
|
| Sep 17 |
TAK vs. STVN: Which Stock Is the Better Value Option?
|
| Sep 17 |
Is Takeda Pharmaceutical Co. (TAK) a Great Value Stock Right Now?
|
| Sep 16 |
Vatroslav Mateljic Appointed General Manager of Takeda Canada
|
| Sep 11 |
Buyout Firm GTCR Is in Advanced Talks to Acquire German Drugmaker Stada
|
| Sep 10 |
Investors are waking up to Centessa’s sleepiness drug
|
